DOCSLIB.ORG

History of the Nobel Prize Winning Research That Shaped Modern

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
History of the Nobel Prize Winning Research That Shaped Modern 0031-6997/07/5904-289–359$20.00 PHARMACOLOGICAL REVIEWS Vol. 59, No. 4 Copyright © 2007 by The American Society for Pharmacology and Experimental Therapeutics 70102/3301314 Pharmacol Rev 59:289–359, 2007 Printed in U.S.A A Brief History of Great Discoveries in Pharmacology: In Celebration of the Centennial Anniversary of the Founding of the American Society of Pharmacology and Experimental Therapeutics RONALD P. RUBIN The State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, New York Foreword .............................................................................. 290 I. Prologue ............................................................................... 290 II. Major discoveries in pharmacology ....................................................... 291 A. Thomas Renton Elliott: elaboration of the concept of chemical neurotransmission .......... 291 B. Sir Henry Dale and Otto Loewi: chemical transmission of nerve impulses ................. 294 1. Sir Henry Dale ................................................................... 294 2. Otto Loewi ....................................................................... 295 C. Daniel Bovet: synthetic compounds that inhibit the action of certain body substances, and Downloaded from especially their action on the vascular system and skeletal muscle ....................... 298 D. Ulf von Euler, Julius Axelrod, and Sir Bernard Katz: humoral transmitters in the nerve terminals and the mechanism for their storage, release, and inactivation ................. 301 1. Ulf von Euler .................................................................... 301 2. Julius Axelrod.................................................................... 301 by guest on March 7, 2017 3. Sir Bernard Katz ................................................................. 305 E. Arvid Carlsson: signal transduction in the nervous system .............................. 306 F. Sir James Black, Gertrude Elion, and George Hitchings: important principles for drug treatment........................................................................... 308 1. Sir James Black .................................................................. 308 2. Gertrude Elion and George Hitchings............................................... 311 G. Paul Ehrlich: the magic bullet ........................................................ 314 H. Gerhard Domagk: antibacterial effects of prontosil ...................................... 315 I. Sir Alexander Fleming, Cecil Paine, Harold Raistrick, Ernst Chain, and Sir Howard Florey: penicillin and its curative effects in various infectious diseases........................... 318 1. Sir Alexander Fleming ............................................................ 318 2. Cecil Paine....................................................................... 320 3. Harold Raistrick.................................................................. 320 4. Ernst Chain and Sir Howard Florey ................................................ 320 5. Jack Strominger .................................................................. 323 J. Selman Waksman: streptomycin: the first antibiotic effective against tuberculosis ......... 324 1. Albert Schatz .................................................................... 326 K. Sir Frederick Banting, Charles Best, John Macleod, and James Collip .................... 327 L. Philip Hench, Edward Kendall, and Tadeus Reichstein: hormones of the adrenal cortex, their structure, and biological effects .................................................. 334 1. Philip Hench ..................................................................... 334 2. Edward Kendall and Tadeus Reichstein............................................. 335 M. Sune Bergstro¨m, Bengt Samuelsson, and John Vane: prostaglandins and related biologically active substances .................................................................... 338 1. Ulf von Euler and Sune Bergstro¨m................................................. 338 Address correspondence to: Dr. Ronald P. Rubin, The State University of New York at Buffalo, School of Medicine and Biomedical Sciences, 102 Farber Hall, Buffalo, NY 14214-3000. E-mail: [email protected] This article is available online at http://pharmrev.aspetjournals.org. doi:10.1124/pr.107.70102. 289 290 RUBIN 2. Bengt Samuelsson ................................................................ 339 3. John Vane ....................................................................... 340 N. Earl W. Sutherland: cyclic AMP....................................................... 342 O. Paul Greengard: signal transduction in the nervous system.............................. 345 P. Martin Rodbell and Alfred G. Gilman: G proteins and their role in signal transduction in cells ............................................................................. 347 1. Martin Rodbell ................................................................... 348 2. Alfred G. Gilman ................................................................. 350 Q. Robert Furchgott, Ferid Murad, and Louis Ignarro: nitric oxide as a signaling molecule in the cardiovascular system.......................................................... 352 1. Robert Furchgott ................................................................. 352 2. Ferid Murad ..................................................................... 353 3. Louis Ignarro .................................................................... 355 III. Epilogue ............................................................................... 356 References ............................................................................. 356 Foreword are developed in such a style that it would be difficult to fault their selection. The lead investigators that When the American Society of Pharmacology and Ex- Dr. Rubin highlights were (or are) remarkable individ- perimental Therapeutics (ASPET1) Centennial Commit- uals. Although each discovery discussed herein culimi- tee began considering ways to celebrate the Society’s nated in a Nobel Prize, many other familiar names are 100th anniversary in 2008, an early interest was ex- woven into the fabric, and the evolution of ideas from pressed in having a publication that presented the re- multiple individuals is emphasized. search history of the discipline. However, the Committee The Centennial Committee is pleased to sponsor recognized that such a tome would fill a very large this publication and hopes that the memories of more volume and be an immense task. senior scientists will be relived and that young scien- Several problems were perceived. First, it would take tists will find the stories inspiring. We give our thanks an enormous effort, one which few authors would be to Dr. Rubin for his efforts and for these fine results. willing to undertake. Second, the likelihood that a qual- ity publication of that magnitude could be produced by William W. Fleming 2008 was slight. Third, no matter how thorough an On behalf of the author might be, the work of many excellent pharmacol- ASPET Centennial Committee ogists would be omitted and could lead to conflicts. Fi- nally, possibly the most important problem would be I. Prologue that the shear mass of material would not attract many young pharmacologists as readers. More than anything This series of essays attempts to profile how extraor- else, the Centennial Committee wants this publication dinary individuals have shaped our concepts in various to be interesting to young scientists. areas of biomedical research, particularly as they relate It came to the attention of the Committee that to the discipline of pharmacology. These gifted research- Dr. Ronald Rubin had been independently considering ers broke through the shibboleths of scientific thought writing about key discoveries in the history of pharma- that dominated their time because of their cogent anal- cology. The Committee offered to sponsor the project. ysis and the accuracy of their hypotheses. Many of the What follows is the outcome of that effort by Dr. Rubin. discoveries that are chronicled in these essays are not In the view of the Committee, what Dr. Rubin has writ- only timeless in terms of their impact on the human ten avoids the major problems noted above. condition but are also inspirational and embody certain The history is written in a highly interesting vein and virtues espoused by Winston Churchill, including “a con- is of a length that can be read in a relatively short period stancy of mind and persistence of purpose.” These essays of time. The theses chosen are of such importance and will also attempt to illustrate how the collaboration of colleagues not only contributed immeasurably to the 1 Abbreviations: ASPET, American Society of Pharmacology and success of a project but may also have led to controver- Experimental Therapeutics; ACh, acetylcholine; NYU, New York sies that even extended into the courts. In perusing a University; NIH, National Institutes of Health; SSRI, selective se- number of documents on a given subject, one is often rotonin reuptake inhibitor; EPP, end-plate potential; ICI, Imperial presented from different perspectives. To deal with this Chemical Industries; DCI, dichloroisoproterenol; 6-MP, 6-mercapto- purine; ACTH, adrenocorticotrophin; NSAID, nonsteroidal anti-in- situation, I have tried to explore as many diverse ac- flammatory drug; PKA, protein kinase A; NO, nitric oxide; EDRF, counts that I felt were needed to
Load more

Recommended publications
  • Alexander Fleming
    PMI Ciência: Mitos, Histórias e Factos A. Fleming Referência: http://www.time.com/time/time100/scientist/profile/fleming.html Alexander Fleming A spore that drifted into his lab and took root on a culture dish started a chain of events that altered forever the treatment of bacterial infections By DR. DAVID HO The improbable chain of events that led Alexander bacteriologist." Although he went on to perform Fleming to discover penicillin in 1928 is the stuff of additional experiments, he never conducted the one which scientific myths are made. Fleming, a young that would have been key: injecting penicillin into Scottish research scientist with a profitable side infected mice. Fleming's initial work was reported in practice treating the syphilis infections of prominent 1929 in the British Journal of Experimental Pathology, London artists, was pursuing his pet theory — that his but it would remain in relative obscurity for a decade. own nasal mucus had antibacterial effects — when he By 1932, Fleming had abandoned his work on left a culture plate smeared with Staphylococcus penicillin. He would have no further role in the bacteria on his lab bench while he went on a two-week subsequent development of this or any other antibiotic, holiday. aside from happily providing other researchers with When he returned, he noticed a clear halo surrounding samples of his mold. It is said that he lacked both the the yellow-green growth of a mold that had chemical expertise to purify penicillin and the accidentally contaminated the plate. Unknown to him, conviction that drugs could cure serious infections.
    [Show full text]
  • Advertising (PDF)
    Neuroscience 2013 SEE YOU IN San Diego November 9 – 13, 2013 Join the Society for Neuroscience Are you an SfN member? Join now and save on annual meeting registration. You’ll also enjoy these member-only benefits: • Abstract submission — only SfN members can submit abstracts for the annual meeting • Lower registration rates and more housing choices for the annual meeting • The Journal of Neuroscience — access The Journal online and receive a discounted subscription on the print version • Free essential color charges for The Journal of Neuroscience manuscripts, when first and last authors are members • Free online access to the European Journal of Neuroscience • Premium services on NeuroJobs, SfN’s online career resource • Member newsletters, including Neuroscience Quarterly and Nexus If you are not a member or let your membership lapse, there’s never been a better time to join or renew. Visit www.sfn.org/joinnow and start receiving your member benefits today. www.sfn.org/joinnow membership_full_page_ad.indd 1 1/25/10 2:27:58 PM The #1 Cited Journal in Neuroscience* Read The Journal of Neuroscience every week to keep up on what’s happening in the field. s4HENUMBERONECITEDJOURNAL INNEUROSCIENCE s4HEMOSTNEUROSCIENCEARTICLES PUBLISHEDEACHYEARNEARLY in 2011 s )MPACTFACTOR s 0UBLISHEDTIMESAYEAR ,EARNMOREABOUTMEMBERAND INSTITUTIONALSUBSCRIPTIONSAT *.EUROSCIORGSUBSCRIPTIONS *ISI Journal Citation Reports, 2011 The Journal of Neuroscience 4HE/FlCIAL*OURNALOFTHE3OCIETYFOR.EUROSCIENCE THE HISTORY OF NEUROSCIENCE IN AUTOBIOGRAPHY THE LIVES AND DISCOVERIES OF EMINENT SENIOR NEUROSCIENTISTS CAPTURED IN AUTOBIOGRAPHICAL BOOKS AND VIDEOS The History of Neuroscience in Autobiography Series Edited by Larry R. Squire Outstanding neuroscientists tell the stories of their scientific work in this fascinating series of autobiographical essays.
    [Show full text]
  • 書 名 等 発行年 出版社 受賞年 備考 N1 Ueber Das Zustandekommen Der
    書 名 等 発行年 出版社 受賞年 備考 Ueber das Zustandekommen der Diphtherie-immunitat und der Tetanus-Immunitat bei thieren / Emil Adolf N1 1890 Georg thieme 1901 von Behring N2 Diphtherie und tetanus immunitaet / Emil Adolf von Behring und Kitasato 19-- [Akitomo Matsuki] 1901 Malarial fever its cause, prevention and treatment containing full details for the use of travellers, University press of N3 1902 1902 sportsmen, soldiers, and residents in malarious places / by Ronald Ross liverpool Ueber die Anwendung von concentrirten chemischen Lichtstrahlen in der Medicin / von Prof. Dr. Niels N4 1899 F.C.W.Vogel 1903 Ryberg Finsen Mit 4 Abbildungen und 2 Tafeln Twenty-five years of objective study of the higher nervous activity (behaviour) of animals / Ivan N5 Petrovitch Pavlov ; translated and edited by W. Horsley Gantt ; with the collaboration of G. Volborth ; and c1928 International Publishing 1904 an introduction by Walter B. Cannon Conditioned reflexes : an investigation of the physiological activity of the cerebral cortex / by Ivan Oxford University N6 1927 1904 Petrovitch Pavlov ; translated and edited by G.V. Anrep Press N7 Die Ätiologie und die Bekämpfung der Tuberkulose / Robert Koch ; eingeleitet von M. Kirchner 1912 J.A.Barth 1905 N8 Neue Darstellung vom histologischen Bau des Centralnervensystems / von Santiago Ramón y Cajal 1893 Veit 1906 Traité des fiévres palustres : avec la description des microbes du paludisme / par Charles Louis Alphonse N9 1884 Octave Doin 1907 Laveran N10 Embryologie des Scorpions / von Ilya Ilyich Mechnikov 1870 Wilhelm Engelmann 1908 Immunität bei Infektionskrankheiten / Ilya Ilyich Mechnikov ; einzig autorisierte übersetzung von Julius N11 1902 Gustav Fischer 1908 Meyer Die experimentelle Chemotherapie der Spirillosen : Syphilis, Rückfallfieber, Hühnerspirillose, Frambösie / N12 1910 J.Springer 1908 von Paul Ehrlich und S.
    [Show full text]
  • Fleming Vs. Florey: It All Comes Down to the Mold Kristin Hess La Salle University
    The Histories Volume 2 | Issue 1 Article 3 Fleming vs. Florey: It All Comes Down to the Mold Kristin Hess La Salle University Follow this and additional works at: https://digitalcommons.lasalle.edu/the_histories Part of the History Commons Recommended Citation Hess, Kristin () "Fleming vs. Florey: It All Comes Down to the Mold," The Histories: Vol. 2 : Iss. 1 , Article 3. Available at: https://digitalcommons.lasalle.edu/the_histories/vol2/iss1/3 This Paper is brought to you for free and open access by the Scholarship at La Salle University Digital Commons. It has been accepted for inclusion in The iH stories by an authorized editor of La Salle University Digital Commons. For more information, please contact [email protected]. The Histories, Vol 2, No. 1 Page 3 Fleming vs. Florey: It All Comes Down to the Mold Kristen Hess Without penicillin, the world as it is known today would not exist. Simple infections, earaches, menial operations, and diseases, like syphilis and pneumonia, would possibly all end fatally, shortening the life expectancy of the population, affecting everything from family-size and marriage to retirement plans and insurance policies. So how did this “wonder drug” come into existence and who is behind the development of penicillin? The majority of the population has heard the “Eureka!” story of Alexander Fleming and his famous petri dish with the unusual mold growth, Penicillium notatum. Very few realize that there are not only different variations of the Fleming discovery but that there are also other people who were vitally important to the development of penicillin as an effective drug.
    [Show full text]
  • Die Woche Spezial
    In cooperation with DIE WOCHE SPEZIAL >> Autographs>vs.>#NobelSelfie Special >> Big>Data>–>not>a>big>deal,> Edition just>another>tool >> Why>Don’t>Grasshoppers> Catch>Colds? SCIENCE SUMMIT The>64th>Lindau>Nobel>Laureate>Meeting> devoted>to>Physiology>and>Medicine More than 600 young scientists came to Lindau to meet 37 Nobel laureates CAREER WONGSANIT > Women>to>Women: SUPHAKIT > / > Science>and>Family FOTOLIA INFLAMMATION The>Stress>of>Ageing > FLASHPICS > / > MEETINGS > FOTOLIA LAUREATE > CANCER RESEARCH NOBEL > LINDAU > / > J.>Michael>Bishop>and GÄRTNER > FLEMMING > JUAN > / the>Discovery>of>the>first> > CHRISTIAN FOTOLIA Human>Oncogene EDITORIAL IMPRESSUM Chefredakteur: Prof. Dr. Carsten Könneker (v.i.S.d.P.) Dear readers, Redaktionsleiter: Dr. Daniel Lingenhöhl Redaktion: Antje Findeklee, Jan Dönges, Dr. Jan Osterkamp where>else>can>aspiring>young>scientists> Ständige Mitarbeiter: Lars Fischer Art Director Digital: Marc Grove meet>the>best>researchers>of>the>world> Layout: Oliver Gabriel Schlussredaktion: Christina Meyberg (Ltg.), casually,>and>discuss>their>research,>or>their> Sigrid Spies, Katharina Werle Bildredaktion: Alice Krüßmann (Ltg.), Anke Lingg, Gabriela Rabe work>–>or>pressing>global>problems?>Or> Verlag: Spektrum der Wissenschaft Verlagsgesellschaft mbH, Slevogtstraße 3–5, 69126 Heidelberg, Tel. 06221 9126-600, simply>discuss>soccer?>Probably>the>best> Fax 06221 9126-751; Amtsgericht Mannheim, HRB 338114, UStd-Id-Nr. DE147514638 occasion>is>the>annual>Lindau>Nobel>Laure- Geschäftsleitung: Markus Bossle, Thomas Bleck Marketing und Vertrieb: Annette Baumbusch (Ltg.) Leser- und Bestellservice: Helga Emmerich, Sabine Häusser, ate>Meeting>in>the>lovely>Bavarian>town>of> Ute Park, Tel. 06221 9126-743, E-Mail: [email protected] Lindau>on>Lake>Constance. Die Spektrum der Wissenschaft Verlagsgesellschaft mbH ist Kooperati- onspartner des Nationalen Instituts für Wissenschaftskommunikation Daniel>Lingenhöhl> GmbH (NaWik).
    [Show full text]
  • Swedish Model of Developing Innovative Drugs: What Happened and Why?
    Acta Scientific Pharmaceutical Sciences (ISSN: 2581-5423) Volume 4 Issue 1 January 2020 Short Communication Swedish Model of Developing Innovative Drugs: What Happened and Why? Jan Olof G Karlsson* Received: December 12, 2019 Division of Drug Research/Pharmacology, Linköping University, Linköping, Published: December 23, 2019 Sweden © All rights are reserved by Jan Olof G *Corresponding Author: Jan Olof G Karlsson, Division of Drug Research/ Karlsson. Pharmacology, Linköping University, Linköping, Sweden. DOI: 10.31080/ASPS.2020.04.0463 - cacious drugs. It has for example been an explosion in our un- American collaborator Sterling Winthrop wanted to add “physi- Still there are large medical needs that are not met with effi it came to the final formulation of Visipaque, Nycomed Imaging’s derstanding of cancer biology but our ability to translate these ological concentration of calcium ions” to it, apparently because it advances into therapies is poor [1]. To developing new drugs is, would sound god when promoting Visipaque. Almén together with a few other scientists realized that such a formulation would put theoretically as well as practically, integrity, creativity, engagement, patients, particularly during coronary angiography, in real danger however, far from an easy task. It demands scientific competence, responsibility and, not at least, critical thinking. - because of increased risk of ventricular fibrillation. The Manage - arguments but not Almén! Later on competitors argue but without cover and develop new drugs that met large medical needs, e.g., ment of Nycomed Imaging was ambivalent for Sterling Winthrop’s Before 1990, the Swedish pharma industry was efficient to dis any proof that Visipaque was more nephrotoxic than its forerun- terbutaline (Bricanyl), felodipin (Plendil), metoprolol (Seloken) ners.
    [Show full text]
  • Curing Childhood Leukemia, October 1997
    This article was published in 1997 and has not been updated or revised. CURING CHILDHOOD LEUKEMIA ancer is an insidious disease. The culprit is not bacterial infections, viral infections, and many other a foreign invader, but the altered descendants illnesses. _) of our own cells, which reproduce uncontrol­ The fight against cancer has been more of a war of lably. In this civil war, it is hard to distinguish friend attrition than a series of spectacular, instantaneous vic­ from foe, to tat;get the cancer cells without killing the tories, and the research into childhood leukemia over the healthy cells. Most of our current cancer therapies, last 40 years is no exception. But most of the children who including the cure for childhood leukemia described here, are victims of this disease can now be cured, and the are based on the fact that cancer cells reproduce without drugs that made this possible are the antimetabolite some of the safeguards present in normal cells. If we can drugs that will be described here. The logic behind those interfere with cell reproduction, the cancer cells will be drugs came from a wide array of research that defined hit disproportionately hard and often will not recover. the chemical workings of the cell--research done by scien­ The scientists and physicians who devised the cure for tists who could not know that their findings would even­ childhood leukemia pioneered a rational approach to tually save the lives of up to thirty thousand children in destroying cancer cells, using knowledge about the cell the United States.
    [Show full text]
  • Lecture Program
    EARL W. SUTHERLAND LECTURE EARL W. SUTHERLAND LECTURE The Earl W. Sutherland Lecture Series was established by the SPONSORED BY: Department of Molecular Physiology and Biophysics in 1997 DEPARTMENT OF MOLECULAR PHYSIOLOGY AND BIOPHYSICS to honor Dr. Sutherland, a former member of this department and winner of the 1971 Nobel Prize in Physiology or Medicine. This series highlights important advances in cell signaling. ROBERT J. LEFKOWITZ, MD NOBEL PRIZE IN CHEMISTRY, 2012 SPEAKERS IN THIS SERIES HAVE INCLUDED: SEVEN TRANSMEMBRANE RECEPTORS Edmond H. Fischer (1997) Alfred G. Gilman (1999) Ferid Murad (2001) Louis J. Ignarro (2003) MARCH 31, 2016 Paul Greengard (2007) 4:00 P.M. 208 LIGHT HALL Eric Kandel (2009) Roger Tsien (2011) Michael S. Brown (2013) 867-2923-Institution-Discovery Lecture Series-Lefkowitz-BK-CH.indd 1 3/11/16 9:39 AM EARL W. SUTHERLAND, 1915-1974 ROBERT J. LEFKOWITZ, MD JAMES B. DUKE PROFESSOR, Earl W. Sutherland grew up in Burlingame, Kansas, a small farming community DUKE UNIVERSITY MEDICAL CENTER that nourished his love for the outdoors and fishing, which he retained throughout INVESTIGATOR, HOWARD HUGHES MEDICAL INSTITUTE his life. He graduated from Washburn College in 1937 and then received his MEMBER, NATIONAL ACADEMY OF SCIENCES M.D. from Washington University School of Medicine in 1942. After serving as a MEMBER, INSTITUTE OF MEDICINE medical officer during World War II, he returned to Washington University to train NOBEL PRIZE IN CHEMISTRY, 2012 with Carl and Gerty Cori. During those years he was influenced by his interactions with such eminent scientists as Louis Leloir, Herman Kalckar, Severo Ochoa, Arthur Kornberg, Christian deDuve, Sidney Colowick, Edwin Krebs, Theodore Robert J.
    [Show full text]
  • Inclusion on the City of Toronto's Heritage Register and Intention to Designate Under Part IV, Section 29 of the Ontario Heritage Act - 100 College Street
    REPORT FOR ACTION Inclusion on the City of Toronto's Heritage Register and Intention to Designate under Part IV, Section 29 of the Ontario Heritage Act - 100 College Street Date: August 7, 2020 To: Toronto Preservation Board Toronto and East York Community Council From: Senior Manager, Heritage Planning, Urban Design, City Planning Wards: Ward 11 - University-Rosedale SUMMARY This report recommends that City Council state its intention to designate the property at 100 College Street under Part IV, Section 29 of the Ontario Heritage Act and include the property on the City of Toronto's Heritage Register. The Banting Institute at 100 College Street, is located on the north side of College Street in Toronto's Discovery District, on the southern edge of the Queen's Park/University of Toronto precinct, opposite the MaRS complex and the former Toronto General Hospital. Following the Nobel-Prize winning discovery of insulin as a life- saving treatment for diabetes in 1921-1922, the Banting Institute was commissioned by the University of Toronto to accommodate the provincially-funded Banting and Best Chair of Medical Research. Named for Major Sir Charles Banting, the five-and-a-half storey, Georgian Revival style building was constructed according to the designs of the renowned architectural firm of Darling of Pearson in 1928-1930. The importance of the historic discovery was recently reiterated in UNESCO's 2013 inscription of the discovery of insulin on its 'Memory of the World Register' as "one of the most significant medical discoveries of the twentieth century and … of incalculable value to the world community."1 Following research and evaluation, it has been determined that the property meets Ontario Regulation 9/06, which sets out the criteria prescribed for municipal designation under Part IV, Section 29 of the Ontario Heritage Act, for its design/physical, historical/associative and contextual value.
    [Show full text]
  • Nobel Prizes
    W W de Herder Heroes in endocrinology: 1–11 3:R94 Review Nobel Prizes Open Access Heroes in endocrinology: Nobel Prizes Correspondence Wouter W de Herder should be addressed to W W de Herder Section of Endocrinology, Department of Internal Medicine, Erasmus MC, ’s Gravendijkwal 230, 3015 CE Rotterdam, Email The Netherlands [email protected] Abstract The Nobel Prize in Physiology or Medicine was first awarded in 1901. Since then, the Nobel Key Words Prizes in Physiology or Medicine, Chemistry and Physics have been awarded to at least 33 " diabetes distinguished researchers who were directly or indirectly involved in research into the field " pituitary of endocrinology. This paper reflects on the life histories, careers and achievements of 11 of " thyroid them: Frederick G Banting, Roger Guillemin, Philip S Hench, Bernardo A Houssay, Edward " adrenal C Kendall, E Theodor Kocher, John J R Macleod, Tadeus Reichstein, Andrew V Schally, Earl " neuroendocrinology W Sutherland, Jr and Rosalyn Yalow. All were eminent scientists, distinguished lecturers and winners of many prizes and awards. Endocrine Connections (2014) 3, R94–R104 Introduction Endocrine Connections Among all the prizes awarded for life achievements in In 1901, the first prize was awarded to the German medical research, the Nobel Prize in Physiology or physiologist Emil A von Behring (3, 4). This award heralded Medicine is considered the most prestigious. the first recognition of extraordinary advances in medicine The Swedish chemist and engineer, Alfred Bernhard that has become the legacy of Nobel’s prescient idea to Nobel (1833–1896), is well known as the inventor of recognise global excellence.
    [Show full text]
  • DMJ.1936.2.1.A02.Young.Pdf (3.644Mb)
    DALHOUSIE MEDICAL JOURNAL 5 A Memorable Conference THE HARVARD TERCENTENARY 1636 - 1936 E. GORDON YOUNG, B.A., M.Sc., Ph.D., F.R.S.C. OMEONE has said that the most valuable and rarest thing in the world S is a new idea. It is the verdict or the intellectual world of science, of art and of music that progress centres largely about the thoughts ex­ pressed by the few great minds of the centuries. The work of the scientists of the world has been likened to a great canvas, the subject of which has been chosen by the few and the first bold lines inserted, but the great mass of colour and detail has been supplied by the many faithful apprentices. It was most fitting that the oldest and greatest of American Universities should celebrate its three hundredth birthday in an intellec­ tual feast and that it should invite to its table as leaders of conversation the greatest minds of the world in those subjects which were proposed for discussion. Harvard.!J.as a magnificent record of intellectual tolerance and its hospitality was open to individuals of all nationalities and all re- ligious and political creeds. To Cambridge thus in the early days of September, 1936, there came, by invitation, a group of about two thousand five hundred American and Canadian scholars to participate in a memorable series of symposia led by a special group of sixty-seven eminent scientists and men of letters from fifteen different countries. These included no fewer than eleven men who had the greatest single distinction in the realms of science and of letters, the Nobel Prize.
    [Show full text]
  • English Summary
    English summary The Nobel Prize Career of Ragnar Granit. A Study of the Prizes of Science and the Science of the Prizes This study is concerned with two closely related themes: the reward system of science – i .e . the various means by which scientists express their admiration and esteem for their colleagues – and the role played by social networks within this broader framework . The study approa- ches its topic from the viewpoint of the Nobel Prize for Physiology or Medicine, often referred to as the Nobel Prize in Medicine . The focus of the study is on the lengthy process that led to the granting of the 1967 Nobel Prize to Ragnar Granit (1901–1991) for his discoveries concer- ning the primary physiological visual processes in the eye . His award was preceded by one of the most dramatic conflicts within the prize authorities during the post-war decades, and serves here to illustrate the dynamics and the various strategies employed in the Nobel Com- mittee of the Karolinska Institute . In addition, Granit’s career as a No- bel Prize candidate is used as a window through which it is possible to examine the various ways in which elite networks in the scientific field operate . In order to enable comparison, the Nobel careers of Charles Best, Hugo Theorell, and John Eccles are also discussed . On a more ge- neral level the Nobel careers of other scientists who received the Nobel Prize in Physiology or Medicine in the period 1940–1960 are also dis- cussed, whereby, as an offshoot of the study, a general picture of the Nobel institution in the post-war decades emerges .
    [Show full text]